Some studies have demonstrated that IL-17 cells mediate host defences against Chagas disease, mucocutaneous leishmaniasis, alveolar disease and opportunistic infections such as pneumocystosis, toxoplasmosis and cryptosporidiosis [38–42]. Here, IL17A is linked to mucocutaneous leishmaniasis.